About REPLIMUNE, INC.
Replimune is a clinical-stage biotech company focused on developing oncolytic immunotherapies to activate a systemic and durable anti-tumor immune response, aiming to revolutionize cancer treatment.
Development of oncolytic immunotherapiesClinical trials in solid tumorsCombination therapy research with other immunotherapies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to REPLIMUNE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.